Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Medical Research Council |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00516347 |
RATIONALE: Learning about how often heartburn and other risk factors occur in brothers and sisters and other family members of patients with Barrett's esophagus may help identify other individuals at risk and identify genes for Barrett's esophagus.
PURPOSE: This clinical trial is studying genes for Barrett's esophagus in brothers and sisters.
Condition | Intervention |
---|---|
Esophageal Cancer Precancerous/Nonmalignant Condition |
Procedure: comparative genomic hybridization Procedure: genetic linkage analysis Procedure: laboratory biomarker analysis Procedure: questionnaire administration Procedure: study of high risk factors |
Study Type: | Observational |
Official Title: | A Sibling Pair Study To Identify Barrett's Oesophagus Susceptibility Genes |
Estimated Enrollment: | 400 |
Study Start Date: | June 2002 |
OBJECTIVES:
Primary
Secondary
OUTLINE: This is a multicenter study.
Patients complete a family history questionnaire. Epidemiological data is also collected about environmental exposures, such as smoking and alcohol history. Any siblings or other living family members affected by heartburn identified from this survey are then contacted to validate their symptoms/diagnoses and to collect other relevant epidemiological data. Family members with heartburn are offered a screening endoscopy for the presence of Barrett's esophagus. In the absence of an endoscopy, a symptom nomogram predictive for the presence of Barrett's esophagus is used.
Patients and their siblings, as well as any other willing family member (affected or non-affected) are asked to have a blood sample (EDTA tube for genetic analysis and a serum sample for Helicobacter pylori status) taken by their physician. Genomic DNA is extracted from lymphocytes and a genome-wide scan is performed using a standard marker set. A computer program is used to verify sibling relationships. Individuals not found to be full siblings are excluded from subsequent analyses. Maximum likelihood score (MLS) and the nonparametric linkage score (NPL) is used to estimate the degree of linkage.
All study participants are flagged with the National Health Service (NHS) Central Register to ascertain the future mortality from esophageal adenocarcinoma compared with deaths from other causes.
PROJECTED ACCRUAL: A total of 200 sibling pairs will be accrued for this study.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United Kingdom, England | |
Hutchison Cancer Research Unit | Recruiting |
Cambridge, England, United Kingdom, CB2 2XZ | |
Contact: Rebecca Fitzgerald, MD 44-1223-763-287 rcf@hutchison-mrc.cam.ac.uk |
Study Chair: | Rebecca Fitzgerald, MD | Hutchison Cancer Research Unit |
Study ID Numbers: | CDR0000561079, MRC-HCRC-MREC-02/2/57, EU-20752 |
Study First Received: | August 14, 2007 |
Last Updated: | July 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00516347 |
Health Authority: | Unspecified |
adenocarcinoma of the esophagus esophageal cancer Barrett esophagus Barrett esophagus |
Digestive System Neoplasms Esophageal disorder Precancerous Conditions Disease Susceptibility Gastrointestinal Diseases Esophageal Neoplasms Digestive System Abnormalities Digestive System Diseases |
Head and Neck Neoplasms Gastrointestinal Neoplasms Barrett Esophagus Esophageal Diseases Genetic Predisposition to Disease Adenocarcinoma Congenital Abnormalities Esophageal neoplasm |
Neoplasms Neoplasms by Site |